(Total Views: 335)
Posted On: 10/26/2017 11:23:22 AM
Post# of 72446
Quote:
In that statement , " should top-line end of study results reflect similar efficacy (and safety) to that observed at interim"
So,even though IPIX didn't release interim data,that doesn't mean they didn't see it.And what did they see???
Not sure what you mean by this.
http://www.ipharminc.com/press-release/2017/3...-treatment
They released the interim data back in March and it looked fantastic.
Go IPIX!
(0)
(0)
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.
